Key SURMOUNT-5 findings UK patients should know Mounjaro produced 20.2% average weight loss vs Wegovys 13.7% in the same trial, at the same time, with the same population Nearly twice as many Mounjaro patients achieved 20%+ weight loss (31.6% vs 16.1%) Three times as many Mounjaro patients achieved 25%+ weight loss (15.4% vs 5.0%) indicating Mounjaros advantage is more pronounced at higher levels of weight loss Tolerability was comparable discontinuation rates due to adverse events were similar between the two medications The practical implication is clear: for patients where maximum weight loss is the primary goal and cost is not a barrier, SURMOUNT-5 provides strong evidence for choosing Mounjaro
Each swap takes zero extra time, uses brands available at any grocery store, and makes the food you're already eating work harder for your body
Pros and Cons of Allan Meds Potential Advantages: Comprehensive program including lifestyle support No long-term contracts Expedited shipping included Flexible dosing options to accommodate individual needs Ability to switch between semaglutide and tirzepatide if needed Potential Limitations: Limited availability in some states Unclear maximum dosage limits No tiered pricing for different doses of compounded medications Compounded medications may not be preferred by all patients Potential for supply chain issues with compounded medications Limited face-to-face interaction compared to traditional medical settings Frequently Asked Questions How does Alan Meds' pricing compare to other telehealth weight loss programs
Think flushing, headaches, hives, itchy skin, bloating, diarrhea, insomnia, and even anxiety